| Sources | Names Used |
|---|---|
| CTRPv2 | compound 1B |
| PharmacoGx | compound 1B |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PPT2-EGFL8 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | C15orf39 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | CTSL | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ZNF821 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | TBC1D22A | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | MAPK3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | MAG | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | RHOT1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | XXYLT1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | PALM3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
